Opicapone Analysis of Health Economic Costs in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0
|
作者：
Lees, A.
Reichmann, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
505
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [41] Influence of baseline OFF-time in the efficacy response of opicapone in Parkinson's disease patients with motor fluctuations: The BIPARK-I double-blind experience
    Korlipara, P.
    Ferreira, J.
    Gama, H.
    Santos, A.
    Ikedo, F.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S177 - S177
  • [42] Efficacy of opicapone compared to entacapone in catechol-O-methyltransferase inhibitor-naive Parkinson's disease patients recently diagnosed with motor fluctuations: A post-hoc conservative analysis
    Ferreira, J.
    Lees, A.
    Ebersbach, G.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S447 - S447
  • [43] Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson's disease: a systematic review and meta-analysis
    Zeglen, Magdalena
    Sladowska, Katarzyna
    Kawalec, Pawel
    Brzostek, Tomasz
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (12) : 889 - 904
  • [44] Efficacy of Opicapone at Different Levodopa Regimens up to a Threshold of 600mg/Day Levodopa in Parkinson's Disease Patients with Motor Fluctuations
    LeWitt, Peter A.
    Stocchi, Fabrizio
    Ferreira, Joaquim J.
    Klepitskaya, Olga
    Magalhaes, Diogo
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    ANNALS OF NEUROLOGY, 2020, 88 : S187 - S188
  • [45] The OCEAN (OpiCapone Effect on motor fluctuations and associated pAiN) study in Parkinson's disease: design and rationale of a randomized double-blind placebo-controlled trial
    Chaudhuri, K.
    Odin, P.
    Ferreira, J.
    Antonini, A.
    Rascol, O.
    Kurtis, M.
    Storch, A.
    Bannister, K.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S164 - S165
  • [46] Impact of opicapone treatment in UPDRS-II and III scores in Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience
    Ebersbach, G.
    Ferreira, J.
    Stocchi, F.
    Costa, R.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 462 - 462
  • [47] OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and-2
    Hauser, Robert A.
    Videnovic, Aleksandar
    Soares-da-Silva, Patricio
    Liang, Grace S.
    Olson, Kurt
    Jen, Eric
    Rocha, Jose-Francisco
    Klepitskaya, Olga
    PARKINSONISM & RELATED DISORDERS, 2024, 123
  • [48] Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function
    O'Sullivan, JD
    Said, CM
    Dillon, LC
    Hoffman, M
    Hughes, AJ
    MOVEMENT DISORDERS, 1998, 13 (06) : 900 - 906
  • [49] Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations
    Carroll, C.
    Lees, A.
    Ferreira, J.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S164 - S164
  • [50] Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study
    Bhidayasiri, Roongroj
    Koebis, Michinori
    Kamei, Takanori
    Ishida, Takayuki
    Suzuki, Ippei
    Cho, Jin Whan
    Wu, Shey-Lin
    FRONTIERS IN NEUROLOGY, 2023, 14
12345